Publication | Open Access

Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors

UrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation Oncology